Clinical trial
Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and…
NCT00498134 · Hospital Authority, Hong Kong, Other · Unknown status
Key facts
| NCT number | NCT00498134 |
|---|---|
| Title | Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway |
| Official title | Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway |
| Lead sponsor | Hospital Authority, Hong Kong, Other |
| Collaborators | The University of Hong Kong |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Stomach Neoplasms |
| Intervention type | Drug |
| Interventions | Triple therapy for H. pylori infection, Cox-2 inhibitor |
| Enrollment | 1,200 |
| Start date | Mar 1, 2004 |
| Completion | Apr 1, 2013 |
| First posted | Jul 9, 2007 |
| Last update posted | Jul 7, 2010 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: